GEMELLI, MARIA
GEMELLI, MARIA
Universita' degli Studi di MILANO
Pathology, molecular biology, medical oncology, and radiotherapy implications of lung neuroendocrine neoplasm classification: a multidisciplinary perspective
2026 G. Pelosi, A. Laffi, G. Catalano, A. Bruno, M. Papotti, B. Bassani, F. Bianchi, E. Duregon, T. Martino De Pas, C. Catania, R. Ricotta, R. Papa, S. Harari, A. Sonzogni, I. Guerriero, C. Ambrosino, K. Pane, M. Franzese, M. Gemelli
Transcriptional evidence of neuroendocrine cell plasticity beyond histological boundaries in lung neuroendocrine neoplasms: an in-silico analysis suggesting a progression model
2026 G. Pelosi, M. Papotti, R. Papa, E. Duregon, M. Gemelli, S. Harari, A. Sonzogni, A. Laffi, T. De Pas, C. Catania, B. Bassani, F. Lotti, A. Bruno, P. Muti, F. Bianchi
Modeling large cell neuroendocrine carcinoma of the lung for molecular, therapeutic and microenvironmental inferences: current knowledge and future perspectives
2025 G. Pelosi, M. Gemelli, F. Bianchi, M. Papotti, E. Duregon, R. Ricotta, R. Papa, S. Harari, A. Sonzogni, A. Laffi, B. Bassani, A. Bruno
Clinical needs and pathology’s answers in neuroendocrine neoplasms of the lung
2025 G. Pelosi, A. Laffi, M. Papotti, S. Lantuejoul, J. Scoazec, M. Gemelli, R. Ricotta, S. Harari, E. Duregon, R. Papa, A. Sonzogni, F. Bianchi, A. Bruno, B. Bassani, S. Uccella, C. Carnaghi, A. Bertuzzi
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC
2024 M. Gemelli, A. Albini, G. Catalano, M. Incarbone, M. Cannone, E. Balladore, R. Ricotta, G. Pelosi